Riccardo Polosa

Riccardo Polosa is a professor of internal medicine and head of the Institute of Internal and Emergency Medicine at the University of Catania in Sicily, Italy, where he founded and currently supervises the Center for Tobacco Research.

He is also the founder and director of the recently created Center of Excellence for the Acceleration of Harm Reduction within the university. Apart from being the scientific advisor for the Italian Anti-Smoking League, he has been chosen as special scientific advisor by the International Network of Nicotine Consumer Organizations, and he maintains his role as coordinator of the working group on requirements and test methods for emissions of e-cigarettes of the European Committee for Standardization.

His main research interests are respiratory diseases, clinical immunology, tobacco-related diseases, smoking prevention and cessation, tobacco harm reduction and risk assessment of new nicotine-containing products.

He is the principal investigator of the first randomized controlled trial in the world on the safety and effectiveness of e-cigarettes in smokers unwilling to quit (ECLAT study, 2013). According to a recent bibliometric analysis published in BMC Public Health, he is the most productive author in the field of e-cigarettes and tobacco harm reduction.